Scholar Rock Holding (SRRK) Accumulated Depreciation (2017 - 2025)
Scholar Rock Holding (SRRK) posted quarterly Accumulated Depreciation of $14.9 million for Q4 2025, up 12.54% year-over-year from $13.2 million in Q4 2024, and up 12.54% quarter-over-quarter from $13.2 million in Q4 2024.
Scholar Rock Holding (SRRK) Accumulated Depreciation (2017 - 2025) Analysis & Trends
Scholar Rock Holding's Accumulated Depreciation history runs 9 years deep, the most recent figure standing at $14.9 million for Q4 2025.
- In Q4 2025, Accumulated Depreciation rose 12.54% year-over-year to $14.9 million; the TTM figure through Dec 2025 stood at $14.9 million (up 12.54% YoY), while the FY2025 annual figure was $14.9 million, up 12.54% from the prior year.
- Accumulated Depreciation for Q4 2025 stood at $14.9 million, up from $13.2 million in the prior quarter.
- The five-year high for Accumulated Depreciation was $14.9 million in Q4 2025, with the low at $7.3 million in Q4 2021.
- The 5-year median for Accumulated Depreciation is $11.3 million (2023), against an average of $11.4 million.
- The sharpest annual moves came in 2021 and 2023: Accumulated Depreciation surged 50.05% in 2021, then rose 10.7% in 2023.
- Scholar Rock Holding's Accumulated Depreciation stood at $7.3 million in 2021, then jumped by 40.32% to $10.2 million in 2022, then grew by 10.7% to $11.3 million in 2023, then advanced by 16.7% to $13.2 million in 2024, then gained by 12.54% to $14.9 million in 2025.
- Business Quant data shows SRRK's Accumulated Depreciation at $14.9 million in Q4 2025, $13.2 million in Q4 2024, and $11.3 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Scholar Rock Holding | 6.39 Bn | 6.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.88 Mn |
| Dec 31, 2024 | 13.22 Mn |
| Dec 31, 2023 | 11.33 Mn |
| Dec 31, 2022 | 10.23 Mn |
| Dec 31, 2021 | 7.29 Mn |
| Dec 31, 2020 | 4.86 Mn |
| Dec 31, 2019 | 3.56 Mn |
| Dec 31, 2018 | 2.36 Mn |
| Sep 30, 2018 | 2.12 Mn |
| Jun 30, 2018 | 1.91 Mn |
| Dec 31, 2017 | 1.55 Mn |